1. Home
  2. SLN vs CTRN Comparison

SLN vs CTRN Comparison

Compare SLN & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$11.51

Market Cap

678.0M

Sector

Health Care

ML Signal

HOLD

Logo Citi Trends Inc.

CTRN

Citi Trends Inc.

HOLD

Current Price

$50.56

Market Cap

559.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLN
CTRN
Founded
1994
1946
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
678.0M
559.1M
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
SLN
CTRN
Price
$11.51
$50.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$42.60
$52.00
AVG Volume (30 Days)
647.9K
161.9K
Earning Date
05-07-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
112.14
EPS
N/A
0.80
Revenue
$559,000.00
$819,962,000.00
Revenue This Year
N/A
$8.81
Revenue Next Year
N/A
$8.35
P/E Ratio
N/A
$67.54
Revenue Growth
N/A
8.88
52 Week Low
$4.19
$29.60
52 Week High
$17.58
$77.91

Technical Indicators

Market Signals
Indicator
SLN
CTRN
Relative Strength Index (RSI) 42.56 N/A
Support Level $4.70 N/A
Resistance Level $15.28 N/A
Average True Range (ATR) 0.58 0.00
MACD -0.23 0.00
Stochastic Oscillator 10.46 0.00

Price Performance

Historical Comparison
SLN
CTRN

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About CTRN Citi Trends Inc.

Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.

Share on Social Networks: